Curcumin is the bright yellow compound in turmeric, and laboratory studies make it look near-miraculous. Your gut barely absorbs it. That blunts most of those promises: human trials show small shifts in inflammation readings, nothing firmer yet.
A landmark pharmacology review documents how poorly standard curcumin dissolves and gets absorbed, which is why enhanced formulations now fill the market. Randomised trials in people with prediabetes or type 2 diabetes report modest drops in markers such as CRP, an inflammation signal read from a blood test. Those trials are short. They switch between formulations and track markers rather than heart attacks, dementia or lifespan.
Doing it: Turmeric the spice is cheap, safe and worth keeping in the pan. If joint aches tempt you toward capsules, pick one reputable product, give it eight to twelve weeks, and stop if nothing changes. If you take warfarin or other blood thinners, ask your pharmacist before starting any new supplement, curcumin included.
Who it suits: Readers with nagging joint pain who want a low-stakes experiment are the right audience. Anyone hoping for organ-level protection should wait for better trials.
Sources
- Anand P et al., Mol Pharm, 2007 (curcumin bioavailability: problems and promises)
- Bahari H et al., Inflammopharmacology, 2025 (SR/MA, curcumin and inflammatory markers)
Prefer to start with what a blood test can tell you? All 48 diagnostic tests, ranked →